Alexander Forero-Torres*, Francisco Reinoso Lozano, Fuad López Fernández and Santiago Valderrabano González

General and Digestive Surgery Department, La Paz University Hospital, Madrid, Spain

*Corresponding Author: Alexander Forero-Torres, General and Digestive Surgery Department, La Paz University Hospital, Madrid, Spain.

Received: August 26, 2021; Published: September 23, 2021

Abstract

  Sickle cell anemia is considered the most common inherited red blood cell disorder. Patients with SCD present a very particular physiological response to surgical and anesthetic stress, and due to the chronic clinical manifestations, they are a perioperative challenge. Since neonatal screening campaigns and prevention and treatment of this disease crises have been carried out, these patients have increased their survival, reaching adulthood and manifesting chronic organic dysfunctions that may require surgical treatment [1].

Surgery in patients with SCD raises an unique challenges due to the chronic manifestations of their disease and especially their physiological response to surgical stress and anesthesia. The perioperative management of the patient with SCD is of vital importance to minimize the appearance of complications associated with surgical interventions, and it is essential to create multidisciplinary teams that offer adequate perioperative management of these patients.

Keywords: Surgery; Sickle Cell Disease (SCD); Sickle Cell Anemia

References

1. Khurmi N., et al. “Perioperative considerations for patients with sickle cell disease: a narrative review”. The Canadian Journal of Anesthesia8 (2017): 860-869.
2. Buck J and Davies SC. “Hematology/Oncology Clinics of North America”. Surgery in Sickle Cell Disease (2005): 898-902.
3. Brumm J., et al. “Sickle Cell Disease is Associated with Increased Morbidity, Resource Utilization, and Readmissions after Common Abdominal Surgeries: A Multistate Analysis, 2007-2014”. Journal Of The National Medical Association2 (2020).
4. Stanley AC and Christian JM. “Sickle cell disease and perioperative considerations: review and retrospective report”. Journal of Oral and Maxillofacial Surgery6 (2013): 1027-1033.
5. Adewale O., et al. “The Inflammatory Response to Surgery in Sickle Cell Disease Patients Undergoing Cholecystectomy”. Journal of the Society of Laparoscopic and Robotic Surgeons2 (2019).
6. Sharma P., et al. “Impact of Bariatric Surgery on Outcomes of Patients with Sickle Cell Disease: a Nationwide Inpatient Sample Analysis, 2004–2014”. Obesity Surgery 29 (2019): 1789-1796.
7. Gerardin C., et al. “Survival and specific outcome of sickle cell disease patients after renal transplantation”. British Journal of Haematology 187 (2019): 676-680.
8. Nielsen L., et al. “Morbidity and mortality of sickle cell disease patients starting intermittent haemodialysis: a comparative cohort study with non-sickle dialysis patients”. British Journal of Haematology 174 (2016): 148-152.
9. Hogen R., et al. “Liver Transplantation in Patients with Sickle Cell Disease in the United States”. Journal of Surgical Research 255 (2020): 23-32.
10. Kwun Lui S., et al. “Orthotropic Liver Transplantation for Acute Intrahepatic Cholestasis in Sickle Cell Disease: Clinical and Histopathologic Features of a Rare Case”. International Journal of Surgical Pathology4 (2019): 411-417.
11. Crawford T C., et al. “Management of sickle cell disease in patients undergoing cardiac surgery”. Journal of Cardiac Surgery 32 (2017): 80-84.

Citation

Citation: Alexander Forero-Torres., et al. “Surgery and Sickle Cell Disease”. Acta Scientific Gastrointestinal Disorders 4.10 (2021): 53-55.

Copyright

Copyright: © 2021 Alexander Forero-Torres., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.